Suvretta Capital Management, LLC Agios Pharmaceuticals, Inc. Transaction History

Suvretta Capital Management, LLC

  • $2.54 Billion
  • Q3 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$19.97 - $24.53 $1.09 Million - $1.34 Million
-54,549 Reduced 12.02%
399,451 $8.9 Million
Q1 2023

May 15, 2023
SELL
$21.74 - $30.93 $5.04 Million - $7.17 Million
-231,772 Reduced 33.8%
454,000 $10.4 Million
Q4 2022

Feb 14, 2023
SELL
$24.81 - $31.52 $6.78 Million - $8.62 Million
-273,442 Reduced 28.51%
685,772 $19.3 Million
Q3 2022

Nov 14, 2022
SELL
$19.51 - $34.14 $26.6 Million - $46.5 Million
-1,362,586 Reduced 58.69%
959,214 $27.1 Million
Q2 2022

Aug 15, 2022
BUY
$17.06 - $31.42 $19.5 Million - $36 Million
1,144,426 Added 97.2%
2,321,800 $51.5 Million
Q4 2021

Feb 14, 2022
SELL
$29.58 - $49.78 $3.97 Million - $6.69 Million
-134,374 Reduced 10.24%
1,177,374 $38.7 Million
Q3 2021

Nov 15, 2021
BUY
$41.92 - $58.18 $13.6 Million - $18.9 Million
324,292 Added 32.84%
1,311,748 $60.5 Million
Q2 2021

Aug 16, 2021
SELL
$52.06 - $61.27 $4.89 Million - $5.75 Million
-93,891 Reduced 8.68%
987,456 $54.4 Million
Q1 2021

May 17, 2021
BUY
$44.23 - $57.5 $39.4 Million - $51.2 Million
891,047 Added 468.23%
1,081,347 $55.8 Million
Q4 2020

Feb 16, 2021
BUY
$33.21 - $46.54 $6.32 Million - $8.86 Million
190,300 New
190,300 $8.25 Million

Others Institutions Holding AGIO

# of Institutions
234
Shares Held
58.3M
Call Options Held
403K
Put Options Held
469K
View Full List

About AGIOS PHARMACEUTICALS, INC.

AGIO Quotes by TradingView
  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $1.83B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Suvretta Capital Management, LLC Portfolio

Follow Suvretta Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email